Cargando…
Early anti-VEGF treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery
BACKGROUND: We report a case of hemorrhagic occlusive retinal vasculitis (HORV) after prophylactic intracameral vancomycin use during an uneventful cataract surgery treated with early anti-VEGF treatment. CASE PRESENTATION: A 51-year-old female underwent uneventful cataract surgery with prophylactic...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719895/ https://www.ncbi.nlm.nih.gov/pubmed/29212481 http://dx.doi.org/10.1186/s12886-017-0632-y |
_version_ | 1783284574764138496 |
---|---|
author | Andreanos, Konstantinos Petrou, Petros Kymionis, George Papaconstantinou, Dimitrios Georgalas, Ilias |
author_facet | Andreanos, Konstantinos Petrou, Petros Kymionis, George Papaconstantinou, Dimitrios Georgalas, Ilias |
author_sort | Andreanos, Konstantinos |
collection | PubMed |
description | BACKGROUND: We report a case of hemorrhagic occlusive retinal vasculitis (HORV) after prophylactic intracameral vancomycin use during an uneventful cataract surgery treated with early anti-VEGF treatment. CASE PRESENTATION: A 51-year-old female underwent uneventful cataract surgery with prophylactic intracameral vancomycin during the procedure. On the seventh post-operative-day, she presented with sudden painful, visual loss. Fundus examination revealed peripheral hemorrhagic retinal vasculitis. She received anti-VEGF therapy to prevent further vision loss and retinal neovascularization due to extensive retinal ischemia. At the 6-month follow-up visit, visual acuity was 20/20 with no sign of neovascularization. CONCLUSIONS: Postoperative HORV is a devastating condition that can occur after otherwise uncomplicated cataract surgery. The nature of this rare condition remains unknown. Early anti-VEGF administration seems to demonstrate favorable results. |
format | Online Article Text |
id | pubmed-5719895 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-57198952017-12-11 Early anti-VEGF treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery Andreanos, Konstantinos Petrou, Petros Kymionis, George Papaconstantinou, Dimitrios Georgalas, Ilias BMC Ophthalmol Case Report BACKGROUND: We report a case of hemorrhagic occlusive retinal vasculitis (HORV) after prophylactic intracameral vancomycin use during an uneventful cataract surgery treated with early anti-VEGF treatment. CASE PRESENTATION: A 51-year-old female underwent uneventful cataract surgery with prophylactic intracameral vancomycin during the procedure. On the seventh post-operative-day, she presented with sudden painful, visual loss. Fundus examination revealed peripheral hemorrhagic retinal vasculitis. She received anti-VEGF therapy to prevent further vision loss and retinal neovascularization due to extensive retinal ischemia. At the 6-month follow-up visit, visual acuity was 20/20 with no sign of neovascularization. CONCLUSIONS: Postoperative HORV is a devastating condition that can occur after otherwise uncomplicated cataract surgery. The nature of this rare condition remains unknown. Early anti-VEGF administration seems to demonstrate favorable results. BioMed Central 2017-12-06 /pmc/articles/PMC5719895/ /pubmed/29212481 http://dx.doi.org/10.1186/s12886-017-0632-y Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Andreanos, Konstantinos Petrou, Petros Kymionis, George Papaconstantinou, Dimitrios Georgalas, Ilias Early anti-VEGF treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery |
title | Early anti-VEGF treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery |
title_full | Early anti-VEGF treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery |
title_fullStr | Early anti-VEGF treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery |
title_full_unstemmed | Early anti-VEGF treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery |
title_short | Early anti-VEGF treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery |
title_sort | early anti-vegf treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719895/ https://www.ncbi.nlm.nih.gov/pubmed/29212481 http://dx.doi.org/10.1186/s12886-017-0632-y |
work_keys_str_mv | AT andreanoskonstantinos earlyantivegftreatmentforhemorrhagicocclusiveretinalvasculitisasacomplicationofcataractsurgery AT petroupetros earlyantivegftreatmentforhemorrhagicocclusiveretinalvasculitisasacomplicationofcataractsurgery AT kymionisgeorge earlyantivegftreatmentforhemorrhagicocclusiveretinalvasculitisasacomplicationofcataractsurgery AT papaconstantinoudimitrios earlyantivegftreatmentforhemorrhagicocclusiveretinalvasculitisasacomplicationofcataractsurgery AT georgalasilias earlyantivegftreatmentforhemorrhagicocclusiveretinalvasculitisasacomplicationofcataractsurgery |